Ibuprofen fails to make monograph threshold
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
The US Food and Drug Administration (FDA) has determined that ibuprofen does not meet the threshold for being permanently added to an OTC monograph and thus non-prescription products containing the analgesic ingredient must be approved through the agency’s new drug application (NDA) process.